Why overdose deaths are falling in the US
Increased access to naloxone and harm reduction supplies have made an impact, according to a recent analysis.
Latest news and analysis on direct care from Healthcare Brew, covering the key trends and regulatory shifts impacting the industry.
Increased access to naloxone and harm reduction supplies have made an impact, according to a recent analysis.
Megan Ranney, who has spent much of her career researching violence prevention, told us what she thinks works (and what doesn’t) to limit firearm-related harm.
The largest percentage is non-melanoma skin cancer, according to federal data.
Longer wait times could lead to worse health outcomes.
Though each state is allowed to create its own initiatives, there are some common themes nationwide.
This month marks the start of Montana’s Medicaid work requirements and national GLP-1 coverage.
The new name opens research on the condition up to more NIH funding, an expert explains.
Healthcare Brew covers pharmaceutical developments, health startups, the latest tech, and how it impacts hospitals and providers to keep administrators and providers informed.
By subscribing, you accept our Terms & Privacy Policy.